The global Over the Counter (OTC) Analgesics Market is estimated to be valued at US$ 28.55 Bn in 2023 and is expected to exhibit a CAGR of 4.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
Over the counter (OTC) analgesics are easily available non-prescription medicines used to relieve pain or reduce fever. They include medicines like aspirin, acetaminophen, ibuprofen and naproxen. OTC analgesics provide quick relief from pain caused due to headache, muscle ache, arthritis, menstrual cramps, backache etc. The easy availability without prescription and affordable price point makes them a preferred choice for self-medication of minor body ache and pains.

Market key trends:
Growing preference for self-medication - With rising health awareness and busy lifestyles, people prefer self-treating minor health issues at home using OTC analgesics instead of visiting a doctor. This growing trend of self-medication is driving the demand for OTC analgesic products.
Innovations in delivery systems - Analgesic manufacturers are investing in new drug delivery technologies like gels, sprays, melting strips etc. to provide fast pain relief. This has increased consumer interest in OTC analgesics.
Aging population - The aging population is more prone to joint disorders, arthritis pain etc. increasing their dependence on pain relief medicines and benefiting the OTC analgesics market.
Porter’s Analysis

Threat of new entrants: Low barrier to entry for OTC analgesics market as manufacturing does not require high capital investment. However, established brands have strong brand recognition and distribution network.

Bargaining power of buyers: Large retailers and pharmacy chains have significant bargaining power due to their sizeable procurement volumes. They can negotiate for lower prices and better trade margins.

Bargaining power of suppliers: Major pharmaceutical companies dominating the market have strong bargaining power over raw material suppliers due to their large procurement volumes.

Threat of new substitutes: Low threat as analgesics in prescription drugs cannot replace OTC analgesics since prescription requires doctor consultation. Nutraceuticals offer alternative but have limitations.

Competitive rivalry: Intense competition due to presence of many global and local players. Players compete on parameters of innovation, brand, quality, and pricing.

Key Takeaways

The Global Over The Counter (OTC) Analgesics Market is expected to witness high growth, exhibiting CAGR of 4.8% over the forecast period, due to increasing availability of generic and herbal OTC analgesics.

Regional analysis: North America dominated the market holding around 40% share in 2023 due to rising healthcare expenditure. Asia Pacific is expected to exhibit fastest growth owing to growing medicinal brand awareness and disposable income in developing countries of the region.

Key players operating in the OTC Analgesics Market are Sanofi SA, Reckitt Benckiser Group PLC, Pfizer Inc., Mylan NV, GlaxoSmithKline PLC, Johnson & Johnson, Bayer, Takeda Pharmaceutical, and Sun Pharmaceutical Industries Ltd., among others. Key players are focusing on strategic partnerships to expand regional presence and new product launches for portfolio expansion.

Read More: https://cmiresearch.blogspot.com/2023/11/increased-demand-for-pain-relief.html